stockportfolio.pro
Harmony Biosciences Holdings, Inc. Gross Profit 2019–2025
Harmony Biosciences Holdings, Inc. (HRMY) annual gross profit by fiscal year, computed from SEC filings. Compound growth +130.9%/yr over 6 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $670.11M | 77.2% | +20.1% |
| FY 2024 | $557.92M | 78.1% | +21.1% |
| FY 2023 | $460.79M | 79.2% | +30.0% |
| FY 2022 | $354.37M | 80.9% | +41.8% |
| FY 2021 | $249.92M | 81.8% | +89.3% |
| FY 2020 | $132.00M | 82.6% | +2887.9% |
| FY 2019 | $4.42M | 73.7% | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s gross profit?
Harmony Biosciences Holdings, Inc. (HRMY) reported gross profit of $670.11M for fiscal year 2025, per its SEC filings.
How has Harmony Biosciences Holdings, Inc.'s gross profit changed over time?
Between fiscal 2019 and 2025, HRMY's gross profit grew at roughly 130.9% per year (compound annual rate), from $4.42M to $670.11M.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.